Paper24944397
Combination therapy for chronic invasive rhinocerebral aspergillosis in a clinically immunocompetent patient.
Lujber L and 3 others. Curr Ther Res Clin Exp, 2003. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Combination therapy for chronic invasive rhinocerebral aspergillosis in a clinically immunocompetent patient. Papers, record 24944397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24944397
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Combination therapy for chronic invasive rhinocerebral aspergillosis in a clinically immunocompetent patient.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10338518 | Interleukin-12 enhances antifungal activity of human mononuclear phagocytes against Aspergillus fumigatus: implications for a gamma interferon-independent pathway. | Infect Immun | 1999 | https://conductscience.org/library/papers/10338518 | PubMed |
| 2 | 4159725 | Aspergilloma of paranasal sinuses and orbit in Northern Sudanese. | Lancet | 1966 | https://conductscience.org/library/papers/4159725 | PubMed |
| 3 | 4200814 | Further observations on the primary paranasal aspergillus granuloma in the Sudan: a morphological study of 46 cases. | Am J Trop Med Hyg | 1973 | https://conductscience.org/library/papers/4200814 | PubMed |
| 4 | 8722837 | The new fungal opportunists are coming. | Clin Infect Dis | 1996 | https://conductscience.org/library/papers/8722837 | PubMed |
| 5 | 8879787 | Therapeutic outcome in invasive aspergillosis. | Clin Infect Dis | 1996 | https://conductscience.org/library/papers/8879787 | PubMed |
| 6 | 3174990 | Fungal sinusitis: diagnosis with CT and MR imaging. | Radiology | 1988 | https://conductscience.org/library/papers/3174990 | PubMed |
| 7 | 1309690 | In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents. | Diagn Microbiol Infect Dis | 1992 | https://conductscience.org/library/papers/1309690 | PubMed |
| 8 | 7596522 | Invasive central nervous system aspergillosis: cure with liposomal amphotericin B, itraconazole, and radical surgery--case report and review of the literature. | Neurosurgery | 1995 | https://conductscience.org/library/papers/7596522 | PubMed |
| 9 | 3393078 | Chronic fungal sinusitis in apparently normal hosts. | Medicine (Baltimore) | 1988 | https://conductscience.org/library/papers/3393078 | PubMed |
| 10 | 1479276 | Rhinocerebral aspergillosis. | J Laryngol Otol | 1992 | https://conductscience.org/library/papers/1479276 | PubMed |
| 11 | 7681040 | Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. | Infect Immun | 1993 | https://conductscience.org/library/papers/7681040 | PubMed |
| 12 | 7948573 | Epidemiology and control of fungal infections. | Clin Infect Dis | 1994 | https://conductscience.org/library/papers/7948573 | PubMed |
| 13 | 10770732 | Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America. | Clin Infect Dis | 2000 | https://conductscience.org/library/papers/10770732 | PubMed |
| 14 | 7598304 | Interferon-gamma in the management of infectious diseases. | Ann Intern Med | 1995 | https://conductscience.org/library/papers/7598304 | PubMed |
| 15 | 5773753 | Primary aspergilloma of paranasal sinuses in the Sudan. A review of seventeen cases. | Br J Surg | 1969 | https://conductscience.org/library/papers/5773753 | PubMed |
| 16 | 3142124 | Primary paranasal Aspergillus granuloma in Saudi Arabia. | Trop Geogr Med | 1988 | https://conductscience.org/library/papers/3142124 | PubMed |
| 17 | 3189365 | Aggressive combined modality treatment of progressive sinonasal fungal infections in immunocompromised patients. | Am J Med | 1988 | https://conductscience.org/library/papers/3189365 | PubMed |
| 18 | 6375518 | Aspergillosis of the paranasal sinuses x-ray diagnosis, histopathology, and clinical aspects. | Ann Otol Rhinol Laryngol | 1984 | https://conductscience.org/library/papers/6375518 | PubMed |
| 19 | 8890991 | Cranial and intracranial aspergillosis of sino-nasal origin. Report of nine cases. | Acta Neurochir (Wien) | 1996 | https://conductscience.org/library/papers/8890991 | PubMed |
| 20 | 9792309 | Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections. | Br J Haematol | 1998 | https://conductscience.org/library/papers/9792309 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 36381625 | Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (rhu GM-CSF) as Adjuvant Therapy for Invasive Fungal Diseases. | Open Forum Infect Dis | 2022 | https://conductscience.org/library/papers/36381625 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24944397
GET https://conductscience.org/api/papers/v1/24944397/references?page=2